跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RILAST TURBUHALER budesonide / formoterol (eformoterol) fumarate dihydrate 400 micrograms/12 micrograms powder for inhalation dry powder inhaler - TGA Drug Approval Details
Approvals
/
TGA
/
RILAST TURBUHALER budesonide / formoterol (eformoterol) fumarate dihydrate 400 micrograms/12 micrograms powder for inhalation dry powder inhaler
Approved
STANDARD
RILAST TURBUHALER budesonide / formoterol (eformoterol) fumarate dihydrate 400 micrograms/12 micrograms powder for inhalation dry powder inhaler
AstraZeneca Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b6dbca9f9fde887d
Company
AstraZeneca Pty Ltd
Type
Standard
Approval Details
Approval Id
b6dbca9f9fde887d
Product Name
RILAST TURBUHALER budesonide / formoterol (eformoterol) fumarate dihydrate 400 micrograms/12 micrograms powder for inhalation dry powder inhaler
Artg Id
295675
Artg Name
RILAST TURBUHALER 400/12 powder for inhalation dry powder inhaler
Sponsor
AstraZeneca Pty Ltd
Company Detail Path
/organization/astrazeneca-pty-ltd
Artg Date
2017-12-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5238db48616dd11273174855f183c8d7.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/d3f36840f0834902f0109c7a47f83dd0.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b6dbca9f9fde887d
Type
Standard
Back to TGA Approvals